Relevant Clinical Trials

How Will the Results of IVAN and CATT 2 Affect Clinical Practice?

How Will the Results of IVAN and CATT 2 Affect Clinical Practice?

Discussion of the results of the IVAN clinical trial and the second year r…

Expiration Date: 5/6/2013

Max Credits: 0

View Activity

What is the Optimal Laser for DME: Green or Yellow?

What is the Optimal Laser for DME: Green or Yellow?

Study results show a difference in visual acuity results comparing investi…

Expiration Date: 5/24/2015

Max Credits: 0

View Activity

What Patients Are More Likely to Be Successfully Treated with Ocriplasmin?

What Patients Are More Likely to Be Successfully Treated with Ocriplasmin?

Ocriplasmin for the Treatment of Patients with VMT and Full-Thickness Macu…

Expiration Date: 9/12/2014

Max Credits: 0

View Activity

Are There Anatomic Predictors of Response to Anti-VEGF Therapy?

Are There Anatomic Predictors of Response to Anti-VEGF Therapy?

Early OCT Responses at Day 7 and Month 1 Post Ranibizumab That Predict Vis…

Expiration Date: 8/26/2015

Max Credits: 0

View Activity

Update on Novel Oral Therapy for DME

Update on Novel Oral Therapy for DME

Administered systemically, ASP-440 is a selective, safe and efficacious in…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Does Aspirin Increase Risk of AMD or Disease Progression?

Does Aspirin Increase Risk of AMD or Disease Progression?

The observational AREDS2 results demonstrate an inverse relationship betwe…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Can Fluoconinole Acetonide Implants Manage Uveitis?

Can Fluoconinole Acetonide Implants Manage Uveitis?

In this analysis of the pooled data from the three fluocinolone acetonide …

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

How Safe and Effective is Ranibizumab in AMD after 7 Years?

How Safe and Effective is Ranibizumab in AMD after 7 Years?

This cohort, representing some of the earliest patients treated with intra…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

What Patients at Risk for Geographic Atrophy?

What Patients at Risk for Geographic Atrophy?

We confirm a substantial high risk of developing GA associated with early …

Expiration Date: 6/5/2015

Max Credits: 0

View Activity

Results from the Restore Extension Study of Ranibizumab for DME

Results from the Restore Extension Study of Ranibizumab for DME

The AEs reported in the interim analysis were consistent with the publishe…

Expiration Date: 6/5/2015

Max Credits: 0

View Activity